Deutsche Bank’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Deutsche Bank’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-385	Closed	-$35K	–	5367
2019 Q2	$35K	Buy	+385	New	+$46.8K	﹤0.01%	4653
2018 Q4	–	Sell	-357	Closed	-$87K	–	5490
2018 Q3	$87K	Buy	357 +341	+2,131%	+$80.7K	﹤0.01%	4546
2018 Q2	$4K	Sell	16 -85	-84%	-$22.8K	﹤0.01%	5281
2018 Q1	$24K	Buy	101 +98	+3,267%	+$25.7K	﹤0.01%	4957
2017 Q4	$1K	Buy	3 +1	+50%	+$329	﹤0.01%	4959
2017 Q3	$0	Sell	2 -13	-87%	-$4.61K	﹤0.01%	5148
2017 Q2	$5K	Buy	+15	New	+$4.49K	﹤0.01%	4757
2017 Q1	–	Hold	0	–	–	–	5157
2016 Q4	–	Hold	0	–	–	–	5120
2016 Q3	–	Sell	-259	Closed	-$53.8K	–	5267
2016 Q2	$50K	Buy	+259	New	+$119K	﹤0.01%	4418

Other funds holding DMK

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Deutsche Bank's DMK Position: Q3 2019 in Review

Deutsche Bank sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2019, closing a stake of 385 shares — an estimated $35K sold.

Deutsche Bank first reported a position in DMK in Q2 2016 and held it in 8 quarters. The position peaked at $87K in Q3 2018. 50 funds tracked by Wall St. Rank hold DMK as of Q3 2019.

Deutsche Bank reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2019 after selling out during the quarter.
Deutsche Bank sold 385 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2019, an estimated $35K.
Deutsche Bank first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2016 and held it in 8 quarters.
Deutsche Bank's DMK Pharmaceuticals Corporation Common Stock position peaked at $87K in Q3 2018.
50 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.